| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.005 | 1 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |